News
OGEN
1.420
+1.43%
0.020
Weekly Report: what happened at OGEN last week (0318-0322)?
Weekly Report · 3d ago
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 4d ago
Weekly Report: what happened at OGEN last week (0311-0315)?
Weekly Report · 03/18 09:37
Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more
Earnings week of March 18 to 22 will feature major quarterly updates from FedEx, XPeng, Tencent, General Mills and more. The week will also feature important announcements from Nike, Lululemon Athletica and Chewy. Technology companies are also in focus with earnings results from Micron, Accenture and others.
Seeking Alpha · 03/17 12:20
Weekly Report: what happened at OGEN last week (0304-0308)?
Weekly Report · 03/11 09:36
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Oragenics, Inc. Is preparing to undertake the final steps of manufacturing and formulation of its drug candidate for its expected Phase IIA clinical trial. The drug candidate is expected to be combined with its novel intranasal device for the treatment of mild Traumatic Brain Injury. Oragenics’ lead drug candidate, ONP-002, is designed to target the brain through self-propelled powdered delivery to the brain.
Barchart · 03/05 06:45
Weekly Report: what happened at OGEN last week (0226-0301)?
Weekly Report · 03/04 09:37
Oragenics Inc Enhances Financial Standing with Equity Sale
TipRanks · 03/01 21:26
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
The Dow Jones index fell around 100 points on Wednesday. U.S. Stocks traded lower toward the end of trading. ADT Inc. Reported better-than-expected earnings for its fourth quarter. Vivani Medical, Inc. Shares shot up 274% to $3.78. Asian markets closed lower in Asia Pacific markets.
Benzinga · 02/28 19:30
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ:BMBL) fell sharply after the company reported weak quarterly results. Vivani Medical, Inc. Shares jumped 289% to $3.93 during Wednesday's mid-day session. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate.
Benzinga · 02/28 19:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Vivani Medical (NASDAQ:VANI) stock increased by 314.4% to $4.19 during Wednesday's regular session. The company's market cap stands at $213.5 million. Adial Pharmaceuticals and vTv Therapeutics moved upwards by 157.73% and 105.88% respectively. Losers Oragenics (AMEX:OGEN) and Novavax stock declined by 42.9%.
Benzinga · 02/28 17:31
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
U.S. Stocks traded lower midway through trading on Wednesday. The Dow traded down 0.19% while the NASDAQ fell 0.31%. Vivani Medical, Inc. Shares shot up 301% to $4.05; real estate shares rose by 1.1% in trading. Crude oil inventories increased by 4.199 million barrels in the week ending Feb. 23, the EIA said. Asian markets closed lower; European shares were mostly lower.
Benzinga · 02/28 17:25
Dow Dips 200 Points; TJX Posts Upbeat Sales
U.S. Stocks traded lower on Wednesday. The Dow Jones index fell around 200 points. The TJX Companies, Inc. Posted better-than-expected sales for its fourth quarter. Energy shares rose by 0.5% on Wednesday while information technology shares fell 0.8%. Asian markets closed lower in trading.
Benzinga · 02/28 15:12
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
Applied Therapeutics (APLT stock is up 58.7% as of Wednesday morning. The FDA has accepted the company’s New Drug Application for govorestat as a treatment for Classic Galactosemia. The drug was granted Priority Review status with a target action date of Aug. 28, 2024. Beyond Meat (BYND) and Oragenics (OGEN) stock are also up on Wednesday.
Investorplace · 02/28 14:48
Oragenics Inc Announces Public Offering Pricing Details
TipRanks · 02/28 14:12
Why Is Integral Ad Science (IAS) Stock Down 29% Today?
Integral Ad Science (NASDAQ:IAS) stock is sliding lower on Wednesday after the company released its earnings report for the fourth quarter of 2023. The digital advertising verification company reported revenue of $134.3 million in its latest earnings report. But the company’s guidance for the first quarter of 2024 isn’t inspiring investors. IAS stock is down 29% as of Wednesday morning.
Investorplace · 02/28 13:55
Why Is Oragenics (OGEN) Stock Down 45% Today?
Oragenics is selling 1.4 million shares of OGEN stock for $1.50 each. Oragenics stock is down 45.3% as of Wednesday morning. The company is selling the shares in a public offering to raise money for its drug development. Beyond Meat and Nauticus Robotics (KITT) stock are up today.
Investorplace · 02/28 13:29
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
Shares of Beyond Meat, Inc. (NASDAQ:BYND) rose sharply in today's pre-market trading. The company reported stronger-than-expected sales for its fourth quarter. Beyond Meat said fourth-quarter revenues decreased 7.8% year-over-year to $73.7 million.
Benzinga · 02/28 13:24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers vTv Therapeutics (NASDAQ:VTVT) shares increased by 104.2% to $17.36 during Wednesday's pre-market session. Vivani Medical's stock moved upwards by 67.32% in Wednesday's session. Genetic Technologies and Imunon also moved upwards. Losers Oragenics (AMEX:OGEN) and Novavax (NVAX) stock fell in the pre- market session.
Benzinga · 02/28 13:06
More
Webull provides a variety of real-time OGEN stock news. You can receive the latest news about Oragenics through multiple platforms. This information may help you make smarter investment decisions.
About OGEN
Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including those caused by coronaviruses and multidrug-resistant organisms. Its lead product NT-CoV2-1 is an intranasal vaccine candidate to prevent coronavirus disease (COVID-19) from the SARS-CoV-2 virus and variants thereof. Its lantibiotics program features a novel class of antibiotics against bacteria its research has shown may be applicable to multiple antibiotic-resistant organisms. Its Antibiotics product is a semi-synthetic analog of MU1140, which is a member of lantibiotic class of antibiotics. Its product pipeline also includes ONP-002, which is a fully synthetic neurosteroid being developed to treat mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC). Through its wholly owned subsidiary, Noachis Terra, is engaged in the research and development stage for its new Terra CoV-2 and NT-CoV2-1 vaccine product candidates.